Interferon (IFN)-alpha 2b is used for adjuvant therapy in malignant melanoma. Neurotoxicity as a side effect has been well described. Resting and action tremor related to interferon have been reported but are relatively uncommon. We report a case of a delayed-onset interferon-related action tremor in a patient with malignant melanoma.

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.coc.0000145982.86749.b4DOI Listing

Publication Analysis

Top Keywords

action tremor
12
malignant melanoma
12
therapy malignant
8
severe action
4
tremor interferon-alpha
4
interferon-alpha therapy
4
melanoma interferon
4
interferon ifn-alpha
4
ifn-alpha adjuvant
4
adjuvant therapy
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!